[ad_1]
Pfizer
The Pfizer laboratory began the procedures on Friday through the Public Health Institute to be able to use its vaccine against the coronavirus in Chile, without the need for a health registry.
T13 indicated that the laboratory tests are already done and the next step would be for the ISP to review and approve the request.
This, however, would have to happen after the resolution that allows the distribution of the vaccine in the United States.
The ISP could render a judgment in late December or early January 2021.
Pfizer has already made a formal request to the US Food and Drug Administration (FDA) to authorize the emergency use of your coronavirus vaccine. It is the first application of its kind and a crucial step in offering protection against the disease.
Loading…
Check the following article
[ad_2]